Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Mark E. Glickman"'
Autor:
Kari R. Gillmeyer, Donald R. Miller, Mark E. Glickman, Shirley X. Qian, Elizabeth S. Klings, Bradley A. Maron, Joseph T. Hanlon, Seppo T. Rinne, Renda S. Wiener
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
Randomized trials of pulmonary vasodilators in pulmonary hypertension due to left heart disease (Group 2) and lung disease (Group 3) have demonstrated potential for harm. Yet these therapies are commonly used in practice. Little is known of the effec
Externí odkaz:
https://doaj.org/article/9ad1bc2aab5d4946bd9a1d24cca962bb
Autor:
Eduardo R. Núñez, Tanner J. Caverly, Sanqian Zhang, Mark E. Glickman, Shirley X. Qian, Jacqueline H. Boudreau, Donald R. Miller, Renda Soylemez Wiener
Publikováno v:
Chest. 162:475-484
Little is known about rates of invasive procedures and associated complications after lung cancer screening (LCS) in nontrial settings.What are the frequency of invasive procedures, complication rates, and factors associated with complications in a n
Autor:
Bradley A. Maron, Joseph T. Hanlon, Shirley Qian, Seppo T. Rinne, Mark E. Glickman, Donald R. Miller, Elizabeth S. Klings, Renda Soylemez Wiener, Kari R. Gillmeyer
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 11 (2021)
Pulmonary Circulation, Vol 11 (2021)
Randomized trials of pulmonary vasodilators in pulmonary hypertension due to left heart disease (Group 2) and lung disease (Group 3) have demonstrated potential for harm. Yet these therapies are commonly used in practice. Little is known of the effec
Publikováno v:
Statistics in medicineREFERENCES. 41(12)
Medication adherence is a problem of widespread concern in clinical care. Poor adherence is a particular problem for patients with chronic diseases requiring long-term medication because poor adherence can result in less successful treatment outcomes
Autor:
Tommy Wright, Linda J. Young, Karen Kafadar, Richard D. De Veaux, Xiao-Li Meng, Xuming He, Bradley Efron, Scott R. Evans, Stephen M. Stigler, Yoav Benjamini, Nancy Reid, Mark E. Glickman, Barry I. Graubard, Christopher K. Wikle, Stephen B. Vardeman
Publikováno v:
The Annals of Applied Statistics. 15
Autor:
Xuming He, Bradley Efron, Nancy Reid, Scott R. Evans, Linda J. Young, Karen Kafadar, Barry I. Graubard, Xiao-Li Meng, Tommy Wright, Mark E. Glickman, Christopher K. Wikle, Stephen B. Vardeman, Stephen M. Stigler, Yoav Benjamini, Richard D. De Veaux
Publikováno v:
Harvard Data Science Review.
The value of hypothesis testing, and the frequent misinterpretation of p-values as a cornerstone of statistical methodology, continues to be debated. In 2019, the President of the American Statisti...
Autor:
Christopher G. Slatore, Renda Soylemez Wiener, Mark E. Glickman, Jacqueline H. Boudreau, Sanqian Zhang, Eduardo R. Nunez, Tanner J. Caverly, Donald R. Miller, Shirley Qian
Publikováno v:
JAMA Network Open
Key Points Question What factors are associated with adherence to recommended testing after initial lung cancer screening in the Veterans Health Administration? Findings In this retrospective cohort study of 28 294 veterans, more than one-quarter of
Autor:
Eduardo R, Núñez, Tanner J, Caverly, Sanqian, Zhang, Mark E, Glickman, Shirley X, Qian, Jacqueline H, Boudreau, Donald R, Miller, Christopher G, Slatore, Renda Soylemez, Wiener
Publikováno v:
JAMA Network Open. 5:e2227126
ImportanceLung cancer screening (LCS) is underused in the US, particularly in underserved populations, and little is known about factors associated with declining LCS. Guidelines call for shared decision-making when LCS is offered to ensure informed,
Autor:
Gilbert Wassermann, Mark E. Glickman
Publikováno v:
Computer Music Journal. 43:142-157
In this article, a combination of two novel approaches to the harmonization of chorales in the style of J. S. Bach is proposed, implemented, and profiled. The first is the use of the bass line, as opposed to the melody, as the primary input into a ch
Autor:
Bradley A. Maron, Renda Soylemez Wiener, Kari R. Gillmeyer, Joseph T. Hanlon, Elizabeth S. Klings, Seppo T. Rinne, Qing Shao, Shirley Qian, Kyung Min Lee, Donald R. Miller, Mark E. Glickman
Publikováno v:
Circ Cardiovasc Qual Outcomes
Background: Use of phosphodiesterase-5 inhibitors (PDE5i) for groups 2 and 3 pulmonary hypertension (PH) is rising nationally, despite guidelines recommending against this low-value practice. Although receiving care across healthcare systems is encou